TherapeuticsMD, Inc.

Nasdaq:TXMD

Pharmaceutical Preparations·BOCA RATON, FL

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K/A	FY 2024	12/31/24	4/30/25	→
10-K	FY 2024	12/31/24	3/27/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
↓

Earnings Releases (8-K)

23 shown

Filed	Period
11/13/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/27/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→
8/12/24	Q3 FY2024	→
↓

News (8-K)

57 shown

Filed	Type	Description
1/21/26	Other	Changes in Registrant's Certifying Accountant	→
12/16/25	Vote	Submission of Matters to a Vote of Security Holders	→
4/9/25	Other	Other Events	→
12/5/24	Vote	Submission of Matters to a Vote of Security Holders	→
9/20/24	Other	8-K Filing	→
8/18/23	Exec Change	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
11/3/25	ARS	ARS	→
10/25/24	ARS	FORM ARS	→
5/18/23	ARS	ARS	→
3/23/22	POSASR	POSASR	→
10/15/21	S-8	S-8	→
8/31/21	S-8	S-8 HUGH O'DOWD INDUCEMENT GRANT	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

8-K

Jan 21, 2026

0001213900-26-005779CURRENT REPORT

Jan 15, 2026

194.9 KB

Dec 29, 2025

0000905148-25-004488

Dec 23, 2025

5.7 KB

8-K

Dec 16, 2025

0001213900-25-122240CURRENT REPORT

Dec 15, 2025

215.3 KB

8-K

Nov 13, 2025

0001213900-25-109479CURRENT REPORT

Nov 12, 2025

213.2 KB

10-Q

Nov 12, 2025

0001213900-25-109381QUARTERLY REPORT

Sep 30, 2025

4.1 MB

Nov 5, 2025

0000905148-25-003785

Nov 3, 2025

5.1 KB

Nov 5, 2025

0000905148-25-003784

Nov 3, 2025

5.1 KB

Nov 5, 2025

0000905148-25-003783

Nov 3, 2025

5.1 KB

Nov 5, 2025

0000905148-25-003782

Nov 3, 2025

5.1 KB

ARS

Nov 3, 2025

0001213900-25-105185ARS

Dec 31, 2024

503.4 KB

DEFA14A

Nov 3, 2025

0001213900-25-105184PROXY STATEMENT

—

3.1 MB

DEF 14A

Nov 3, 2025

0001213900-25-105183PROXY STATEMENT

Dec 15, 2025

18.1 MB

PRE 14A

Oct 24, 2025

0001213900-25-102166PROXY STATEMENT

Oct 24, 2025

18.2 MB

10-Q

Aug 12, 2025

0001213900-25-075003QUARTERLY REPORT

Jun 30, 2025

4.1 MB

8-K

Aug 12, 2025

0001213900-25-074975CURRENT REPORT

Aug 12, 2025

228.6 KB

10-Q

May 13, 2025

0001213900-25-042697QUARTERLY REPORT

Mar 31, 2025

4.2 MB

8-K

May 13, 2025

0001213900-25-042663CURRENT REPORT

May 13, 2025

243.4 KB

10-K/A

Apr 30, 2025

0001213900-25-037713AMENDMENT NO. 1 TO FORM 10-K

Dec 31, 2024

621.6 KB

Apr 15, 2025

0000905148-25-001216

Apr 14, 2025

6.2 KB

Apr 15, 2025

0000905148-25-001215

Apr 14, 2025

4.3 KB

Apr 10, 2025

0000905148-25-001190

Apr 9, 2025

6.2 KB

8-K

Apr 9, 2025

0001213900-25-030089CURRENT REPORT

Apr 8, 2025

192.1 KB

10-K

Mar 27, 2025

0001013762-25-003442ANNUAL REPORT

Dec 31, 2024

6.8 MB

8-K

Mar 27, 2025

0001013762-25-003407CURRENT REPORT

Mar 27, 2025

226.4 KB

Feb 20, 2025

0000905148-25-000740

Feb 18, 2025

6.6 KB

25 filings shown

Filed	Form	Description
2/12/25	SCHEDULE 13G	SCHEDULE 13G	→
6/14/24	AW	AMENDMENT WITHDRAWAL REQUEST	→
12/6/23	144	144	→
7/11/23	D	D	→
11/14/22	D	D	→
10/17/22	D	D	→
↓

TherapeuticsMD, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/29/25	4	4	→
11/5/25	4	4	→
11/5/25	4	4	→
11/5/25	4	4	→
11/5/25	4	4	→
4/15/25	4	4	→
↓